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ABSTRACT  
The spectra of phenotypes associated with aging and mitochondrial diseases sometimes 
appear to overlap with each other. We used aged mice and a mouse model of 
mitochondrial diseases (transmitochondrial mito-miceΔ with deleted mtDNA) to study 
whether premature aging phenotypes observed in mtDNA mutator mice are associated 
with aging or mitochondrial diseases. Here, we provide convincing evidence that all the 
mice examined had musculoskeletal disorders of osteoporosis and muscle atrophy, 
which correspond to phenotypes prevalently observed in the elderly. However, precise 
investigation of musculoskeletal disorders revealed that the spectra of osteoporosis and 
muscle atrophy phenotypes in mtDNA mutator mice were very close to those in mito-
miceΔ, but different from those of aged mice. Therefore, mtDNA mutator mice and 
mito-miceΔ, but not aged mice, share the spectra of musculoskeletal disorders. 
 
1. Introduction 
Human mtDNA with pathogenic mutations that induce mitochondrial respiration defects 
has been proposed to cause mitochondrial diseases, and could also be involved in aging 
3 
[1-5]. This concept (mitochondria theory of aging) is supported by studies in mtDNA 
mutator mice [6, 7]. In these mice, proofreading-defective mtDNA polymerase 
enhances accumulation of somatic mtDNA mutations and leads to age-associated 
respiration defects and various premature aging phenotypes.  
In contrast, our previous studies revealed that age-associated respiration defects found 
in human fibroblasts are caused not by mtDNA mutations [8, 9] but by nuclear-
recessive mutations [9]. Moreover, transmitochondrial mito-mice carrying mtDNA with 
a large-scale deletion (mito-miceΔ) showed age-associated accumulation of the mutated 
mtDNA and the resultant expression of phenotypes of mitochondrial diseases, but had 
no premature aging phenotypes [10, 11]. Therefore, it appeared to be controversial that 
mtDNA mutator mice, but not mito-miceΔ, express premature aging phenotypes, even 
though both mice express age-associated respiration defects due to age-associated 
accumulation of mtDNA with mutations.  
Our subsequent study [12] revealed that the apparent discrepancy was partly due to the 
differences in the nuclear genetic backgrounds of mtDNA mutator mice and mito-
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miceΔ: by generating mtDNA mutator mice that share the same C57BL/6J (B6J) 
nuclear genetic background as that of mito-miceΔ, we showed that both mouse models 
commonly exhibit premature aging phenotypes of kyphosis and a short lifespan, but do 
not express premature aging phenotypes of graying and alopecia [12]. Thus, the spectra 
of abnormalities in the mtDNA mutator mice with a B6J nuclear background are very 
similar to those of mito-miceΔ that express phenotypes of mitochondrial diseases [10, 
11]. 
The question that then arises is whether mtDNA mutator mice correspond to a model of 
aging or mitochondrial diseases. Here we addressed this issue by using aged mice and 
mito-miceΔ as positive controls for aging and mitochondrial diseases, respectively, and 
investigated precisely musculoskeletal disorders, including osteoporosis and muscle 
atrophy, which have been reported in elderly human subjects [13] and mtDNA mutator 
mice [6, 7]. 
2. Materials and methods 
2.1. Mice 
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Inbred B6J mice generated by sibling mating more than 40 times were obtained from 
CLEA Japan. Mito-miceΔ and mtDNA mutator mice were generated in our previous 
studies [10, 12]. Animal experiments were performed in accordance with protocols 
approved by the Experimental Animal Committee of the University of Tsukuba, Japan.  
2.2. Micro-computed tomography analysis 
The µ-CT (Scan X mate E090S scanner, Comscantechno, Kanagawa, Japan) was used 
to take tomography images at three parts in mouse tibia bones. The µ-CT was operated 
at a tube voltage peak of 90 kV and a tube current of 90 mA. Samples were rotated 360° 
in steps of 0.6°, generating 600 projection images of 992 × 992 pixels. The µ-CT data 
were reconstructed at an isotropic resolution of 22.4×22.4×22.4 mm3 (the wide part of 
tibia) and 7×7×7 mm3 (the proximal metaphysis and the mid-diaphysis). 0.1mm brass 
filter was used for the scanning of the wide part of tibia and the mid-diaphysis. For each 
analysis, the region of interest (ROI) was defined on the basis of an anatomical feature 
(Fig. S1).  Morphometric indices were calculated using TRI/3D-BON (RATOC System 
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Engineering, Tokyo, Japan) software. Bone mineral density of tibia bones were 
measured using TRI/3D-BON-BMD (RATOC Systems) software. 
2.3. Quantitative RT-PCR 
Total RNA was extracted from mouse quadriceps muscles by using the RNeasy fibrous 
mini kit (Qiagen, Hilden, Germany). RNA samples were reverse transcribed by using 
QuantiTect Reverse Transcription Kit (Qiagen). Real-time monitoring PCR was 
performed with QuantiTect SYBR Green PCR Kit (Qiagen), an ABI PRISM 7900HT 
sequence detection system (Applied Biosystems, CA, USA), and primers for atrogin-1 
(forward, ctctgtaccatgccgttcct; reverse, ggctgctgaacagattctcc)  and TATA-box binding 
protein (forward, ggcggtttggctaggttt; reverse: gggttatcttcacacaccatga). The relative 
expression level of atrogin-1 mRNA was calculated by using ΔΔCt method. The gene 
encoding TATA-box binding protein was used as an internal control. The proportion of 
wild type mtDNA and ΔmtDNA was determined by real-time PCR analysis, as 
described previously [12]. 
2.4. Ex vivo differentiation of osteoclasts and osteoblasts 
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Bone marrow macrophages were induced by incubating bone marrow flushed from 
mouse femurs and tibiae with macrophage inducing medium: MEMα Glutamax (Gibco, 
CA, USA) containing 10% fetal bovine serum (FBS) and 10 ng/mL recombinant 
macrophage colony stimulating factor 1 (M-CSF) (Wako, Osaka, Japan), and purified 
by Ficoll-Hypaque (GE Healthcare, Buckinghamshire, UK) gradient centrifugation. 
Osteoclasts were induced by incubating bone marrow macrophages in MEMα 
Glutamax containing 10% FBS, 50 ng/mL recombinant M-CSF, and 100ng/mL 
recombinant receptor activator of nuclear factor kappa-B ligand (RANKL) (Wako) for 5 
days. Pre-osteoblasts were selected from bone marrow by incubating whole bone 
marrow cells in RPMI1640 (Nissui, Tokyo, Japan) containing 10% FBS for 7 days. 
Osteoblasts were induced by incubating pre-osteoblasts in RPMI1640 containing 
Osteoblast-Inducer Reagent (TaKaRa, Shiga, Japan) for 14 days. Cytochemical analysis 
of cytochrome c oxidase (COX) activity of osteoclasts and osteoblasts was performed as 
described previously [12]. 
2.5. Histological Analyses  
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Frozen sections (10-µm) of quadriceps muscles were used for COX and H&E staining, 
as described previously [12]. Cross sectional area (CSA) of skeletal muscle fibers was 
calculated from H&E stained section by using ImageJ (Rasband, WS., Image J, U.S. 
National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-
2014) software. 
2.6. Statistical Analysis  
Data were analyzed by two-sided Student’s t-test. P values of less than 0.05 were 
considered significant. 
3. Results 
First we compared bone mineral density (BMD) in aged mice, mtDNA mutator mice, 
and mito-miceΔ, because decreased BMD is an osteoporosis phenotype prevalent in 
elderly human subjects and a phenotype observed in mtDNA mutator mice. We carried 
out quantitative estimation of BMD in tibia bones (Fig. S1A), and showed that its 
expression was significantly decreased in aged mice, mtDNA mutator mice, and mito-
miceΔ compared with young mice (Fig. 1A).  
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For further investigation of the structural abnormalities associated with the decreased 
BMD (Fig. 1B), we performed X-ray micro-computed tomography (µ-CT) analysis of 
trabecular and cortical bones (Fig. S1B and C). Quantitative estimation of trabecular 
bone volume (Fig. 1C) and cortical bone thickness (Fig. 1D) showed that cortical bone 
thickness, but not trabecular bone volume, decreased in both mtDNA mutator mice and 
mito-miceΔ; in contrast, aged mice did not show a significant decrease in either 
trabecular bone volume or cortical bone thickness. Together with the finding that elderly 
human subjects exhibit a decrease in trabecular bone volume but not cortical bone 
thickness [14], our result suggests that decreased cortical bone thickness exclusively 
found in mtDNA mutator mice and mito-miceΔ is not associated with either mouse or 
human aging. 
We then compared respiratory function by using osteoclasts and osteoblasts, which play 
an important role in bone metabolism. Cytochemical analysis of mitochondrial 
cytochrome c oxidase (COX) activity showed reduced activity in the cells of mtDNA 
mutator mice and mito-miceΔ, but not in the cells of aged mice, when compared with 
young mice (Fig. 1E). These results indicate that the decreased BMD (Fig. 1A) and 
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cortical bone thickness (Fig. 1D) observed in mtDNA mutator mice and mito-miceΔ are 
likely due to respiration defects, whereas the decreased BMD observed in aged mice 
(Fig. 1A) occurred in the absence of the respiration defects (Fig. 1E). 
Next, we investigated muscle atrophy, another typical aging phenotype of 
musculoskeletal disorders, which is observed not only in elderly human subjects [13] 
and mtDNA mutator mice [6, 7], but also in patients with mitochondrial diseases [15], 
cachexia, or sepsis [16]. By isolating and measuring the weight of quadriceps muscles 
(Fig. 2A and B), we observed muscle atrophy in aged mice, mtDNA mutator mice, and 
mito-miceΔ compared with young mice. Furthermore, histochemical analysis also 
showed atrophy of each muscle fiber (Fig. 2C and D), which confirmed the presence of 
muscle atrophy in the quadriceps of all three mouse models.  
Comparison of the mitochondrial respiratory function of quadriceps was performed by 
histochemical analysis of COX activity. Decreased COX activity relative to that in 
young mice was observed in muscle fibers of mtDNA mutator mice and mito-miceΔ, 
but not in aged mice (Fig. 2E). Therefore, mitochondrial respiration defects could be 
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responsible for the muscle atrophy expressed in mtDNA mutator mice and mito-miceΔ, 
whereas aged mice had muscle atrophy in the absence of the respiration defects. 
Decreased COX activity in muscle fibers corresponds to mitochondrial myopathy, 
which is one of the typical abnormalities frequently observed in patients with 
mitochondrial diseases [1, 4]. Therefore, mtDNA mutator mice and mito-miceΔ also 
share a phenotype associated with mitochondrial diseases.  
For further investigation of muscle atrophy, we examined atrogin-1 mRNA levels, 
because overexpression of the atrogin-1 gene, which encodes an E3 ubiquitin ligase 
involved in proteolysis, is observed in human muscle atrophy caused by cachexia, 
sepsis, or immobilization [16], but not in age-associated muscle atrophy (sarcopenia) 
developed in the elderly [17]. Here we observed that atrogin-1 mRNA was 
overexpressed in quadriceps of both mtDNA mutator mice and mito-miceΔ, but not in 
aged mice, relative to the levels in young mice (Fig. 2F). These observations suggest 
that the mechanisms behind muscle atrophy in mtDNA mutator mice are similar to those 
in mito-miceΔ, but differ from those in aged mice and elderly human subjects, that 
develop muscle atrophy in the absence of atrogin-1 overexpression.  
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4. Discussion 
The mitochondrial theory of aging [1-5] proposes a vicious cycle of age-associated 
accumulation of somatic mutations in mtDNA and the resultant respiration defects and 
overproduction of reactive oxygen species (ROS). This concept was partly supported by 
studies in mtDNA mutator mice, which had premature aging phenotypes along with the 
accumulation of somatic mutations in mtDNA, although they did not display ROS 
overproduction [7, 18]. However, mito-miceΔ showing age-associated accumulation of 
the mutated mtDNA and the resultant respiration defects had no premature aging 
phenotypes [10, 11]. We addressed to the controversial issue that mtDNA mutator mice, 
but not mito-miceΔ, express premature aging phenotypes, and revealed that decreased 
cortical bone thickness (Fig. 1D) and overexpression of atrogin-1 in muscle atrophy 
(Fig. 2F) were exclusively observed in mtDNA mutator mice and mito-miceΔ, but not 
in aged mice.  
Therefore, the spectra of musculoskeletal disorders in mtDNA mutator mice and mito-
miceΔ are similar to each other, but different from those in aged mice. Considering that 
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the spectra of musculoskeletal disorders in mtDNA mutator mice and mito-miceΔ are 
also different from those in elderly human subjects [14, 17], they would not be 
associated with either mouse or human aging. Then, a question that arises is whether 
decreased cortical bone thickness and increased atrogin-1 mRNA expression in muscle 
fibers are associated with mitochondrial diseases. To answer this question, further works 
are required to investigate whether the patients with mitochondrial diseases express 
these abnormalities.  
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Figure legends 
Fig. 1. Characterization of phenotypes of osteoporosis displayed in tibia bones of 
mtDNA mutator mice. Aged mice and mito-miceΔ were used as controls expressing 
phenotypes associated with aging and mitochondrial diseases, respectively. All mice 
were males sharing the B6J nuclear genetic background. Young, 10-month-old mice; 
Aged, 27-month-old mice; Mutator, 10-month-old mtDNA mutator mice; Delta, 10-
month-old mito-miceΔ. The proportions of ΔmtDNA in the tail from mito-miceΔ were 
57.5 ± 2.5 % at 4 weeks after birth and 81.2 ± 1.3 % at 10 months old. (A) Quantitative 
estimation of BMD. Data are means ± SD. *, P < 0.05 (n = 3). (B) µ-CT analysis of 
trabecular and cortical bones. Upper panel, red-colored areas correspond to trabecular 
bones; lower panel, bone areas exclusively consisting of cortical bones (gray-colored 
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areas). Scale bar, 500 µm. (C) Quantitative estimation of the ratio of trabecular bone 
volume/ tissue volume (BV/TV). Data are means ± SD. *, P < 0.05 (n = 3). (D) 
Quantitative estimation of cortical bone thickness (Ct). Data are means ± SD. *, P < 
0.05 (n = 3). (E) Cytochemical analysis of COX activity. OCs, osteoclasts; OBs, 
osteoblasts. Cells that had lost their COX activity were detected as a blue color. The 
proportions of ΔmtDNA in the bone marrow cells, osteoclasts, and osteoblasts were 
65.1 %, 61.5 %, and 57.7 %, respectively. Scale bars, 50 µm.  
Fig. 2. Characterization of phenotypes of muscle atrophy displayed in quadriceps of 
mtDNA mutator mice. Aged mice and mito-miceΔ were used as controls of phenotypes 
associated with aging and mitochondrial disease, respectively. All mice were males 
sharing the B6J nuclear genetic background. Young, 10-month-old mice; Aged, 27-
month-old mice; Mutator, 10-month-old mtDNA mutator mice; Delta, 10-month-old 
mito-miceΔ. (A) Images of whole quadriceps. The proportions of ΔmtDNA in the 
quadriceps from mito-miceΔ were 82.6 %. Scale bar, 5 mm. (B) Tissue weights of 
quadriceps. The proportions of ΔmtDNA in the quadriceps muscles from mito-miceΔ 
were 83.1 ± 2.2 %. Data are means ± SD. *, P < 0.05 (n = 3). (C) Hematoxylin and 
eosin (H&E) staining of muscle fibers in quadriceps. The proportions of ΔmtDNA in 
the quadriceps from mito-miceΔ were 83.2 %. Scale bar, 50 µm. (D) Quantitative 
estimation of cross-sectional areas (CSA) of each muscle fiber. The proportions of 
ΔmtDNA in the quadriceps muscles from mito-miceΔ were 82.9 ± 2.1 %. Data are 
means ± SD. *, P < 0.05. (E) Histochemical analysis of COX activity in quadriceps. 
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The intensity of brown-staining represents the level of COX activity. The proportions of 
ΔmtDNA in the quadriceps from mito-miceΔ were 82.7 %. Scale bar, 50 µm. (F) 
Estimation of the mRNA levels of atrogin-1 in quadriceps by using quantitative real-
time PCR. The proportions of ΔmtDNA in the quadriceps muscles from mito-miceΔ 
were 83.0 ± 1.8 %. Data are means ± SD. *, P < 0.05 (n = 4). 
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